CAMEO+ eventCORPORATE2026-04-20馃嚞馃嚙
Company announcement: strategic technology collaboration deal
source: Genflow Biosciences Plc -> target: Acuitas Therapeutics
On 2026-04-20, Genflow Biosciences announced a strategic technology collaboration with Acuitas Therapeutics for access to Acuitas' lipid nanoparticle delivery platform. The companies described the deal as fully funded and non-dilutive, with Genflow framing it as support for its gene therapy development work.
0.12Significance1.0Magnitude0.1Systemic0.1Market1Articles
Location
LondonEuropeUnited KingdomEurope51.507, -0.128
Story Links